GleamWall
中文EN

USPH U S PHYSICAL THERAPY INC /NV

Services-Health Services · NYSE · SEC CIK 885978 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY10.4%
TTM net income YoY-32.5%
TTM EPS YoY-156.1%
Revenue 3-yr CAGR12.3%
Net income 3-yr CAGR-0.1%

Margins

Gross margin18.8%
Operating margin9.1%
Net margin3.6%
FCF margin8.2%
EBITDA margin11.7%

Returns

ROE6.5%
ROA2.4%
ROIC (approx.)9.1%
Asset turnover0.67x

Leverage & solvency

Liabilities / assets39.2%
Debt / equity0.57x
Current ratio1.42x
Interest coverage—

Cash quality & payout

Operating cash flow / net income2.95x
Accruals ratio-4.7%
Payout ratio—
Capex / revenue2.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$222.56M$214.06M$198.29M$202.73M$197.13M$197.34M$183.79M$180.45M
Gross profit$43.03M$41.94M$32.75M$40.13M$36.87M$41.62M$31.07M$32.53M
SG&A expense$17.83M$19.00M$18.27M$18.12M$17.41M$17.48M$16.25M$15.57M
Operating income$25.10M$21.95M$12.48M$16.77M$25.33M$24.94M$19.64M$19.65M
Pretax income$21.56M$19.05M$10.56M$14.96M$22.88M$22.65M$17.33M$18.32M
Income tax$3.97M$4.16M$2.41M$5.78M$5.23M$4.93M$3.86M$5.83M
Net income$11.04M$9.90M$5.04M$4.15M$13.14M$12.39M$9.90M$9.24M
EBITDA$30.97M$27.57M$18.48M$21.40M$30.82M$30.68M$25.51M$25.34M
EPS (basic)-1.040.25-0.12—0.480.580.80—
EPS (diluted)-1.040.25-0.12—0.480.580.80—
Dividends declared per share0.460.460.460.450.450.450.450.44
Weighted avg. shares (diluted)14.93M15.07M15.17M—15.20M15.20M15.13M—
Balance sheet
Cash & equivalents$38.23M$24.89M$28.44M$35.57M$31.10M$34.09M$39.18M$41.36M
Receivables$63.22M$69.60M$69.08M$64.25M$67.63M$65.96M$64.76M$59.04M
Current assets$154.76M$139.68M$139.11M$139.99M$138.44M$140.53M$145.35M$137.58M
PP&E, net$42.21M$40.43M$38.62M$35.65M$34.22M$32.12M$32.76M$32.14M
Goodwill$732.80M$716.53M$715.87M$692.39M$692.39M$677.60M$674.39M$667.15M
Intangibles$180.37M$176.55M$179.82M$172.86M$176.43M$175.63M$177.33M$179.31M
Total assets$1.30B$1.25B$1.24B$1.20B$1.20B$1.18B$1.18B$1.17B
Current liabilities$109.22M$109.91M$117.30M$139.04M$115.08M$118.84M$123.80M$116.28M
Short-term debt$4.42M$4.56M$10.80M$9.87M$8.80M$8.17M$9.26M$11.00M
Long-term debt$241.69M$215.46M$194.04M$152.59M$151.46M$151.91M$157.24M$142.53M
Total debt$246.10M$220.02M$204.84M$162.46M$160.26M$160.08M$166.50M$153.53M
Total liabilities$508.36M$482.22M$459.19M$433.81M$413.83M$414.01M$420.68M$408.42M
Shareholders' equity$429.30M$448.66M$468.98M$476.43M$503.57M$500.75M$497.26M$488.93M
Net debt$207.88M$195.13M$176.40M$126.89M$129.16M$126.00M$127.31M$112.17M
Cash flow statement
Operating cash flow$25.72M$34.37M$3.81M$24.93M$19.94M$34.86M-$4.67M$19.41M
Capital expenditure$5.07M$5.36M$5.37M$3.93M$4.32M$3.25M$2.58M$2.49M
Free cash flow$20.65M$29.01M-$1.56M$21.01M$15.62M$31.61M-$7.25M$16.92M
Investing cash flow-$26.48M-$6.41M-$39.80M-$5.44M-$11.94M-$12.71M-$6.63M-$94.85M
Financing cash flow$14.09M-$31.52M$28.86M-$15.02M-$10.99M-$27.25M$9.12M-$153,000
Depreciation & amortization$5.87M$5.62M$6.00M$4.63M$5.50M$5.74M$5.87M$5.68M
Stock-based compensation$3.00M$2.40M$2.31M$2.12M$2.30M$2.00M$1.77M$1.99M
Dividends paid$6.86M——$6.84M$6.84M——$6.64M
Share buybacks$0——$5.57M$0———

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.